246 related articles for article (PubMed ID: 37032358)
21. Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL).
Somasundaram N; Lim JQ; Ong CK; Lim ST
J Hematol Oncol; 2019 Mar; 12(1):28. PubMed ID: 30876435
[TBL] [Abstract][Full Text] [Related]
22. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
23. Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma.
Mustafa N; Nee AHF; Chooi JY; Toh SHM; Chung TH; Selvarajan V; Fan S; Ng SB; Poon M; Chan E; Lee J; Chee YL; Jeyasekharan AD; Zhou L; Yang J; Chng WJ
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34215687
[TBL] [Abstract][Full Text] [Related]
24. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
[TBL] [Abstract][Full Text] [Related]
25. The super-enhancer repertoire in porcine liver.
Zhang Y; Zhang J; Wang C; Dai H; Du X; Li Q; Pan Z
J Anim Sci; 2023 Jan; 101():. PubMed ID: 36800318
[TBL] [Abstract][Full Text] [Related]
26. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
[TBL] [Abstract][Full Text] [Related]
27. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.
Paik JH; Jang JY; Jeon YK; Kim WY; Kim TM; Heo DS; Kim CW
Clin Cancer Res; 2011 Jul; 17(14):4761-71. PubMed ID: 21610143
[TBL] [Abstract][Full Text] [Related]
29. A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-κB signaling.
Kim A; Lee JE; Jang WS; Lee SJ; Park S; Kang HJ; Lee SS
Leuk Res; 2012 Mar; 36(3):350-7. PubMed ID: 21893341
[TBL] [Abstract][Full Text] [Related]
30. Sildenafil prevents HDACi-induced Epstein-Barr virus reactivation through the PKG pathway in NK/T cell lymphoma; potential implications for HDACi-mediated fatal complications.
Kim JH; Kim WS; Park C
Antiviral Res; 2021 May; 189():105063. PubMed ID: 33741394
[TBL] [Abstract][Full Text] [Related]
31. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma.
Li YX; Liu QF; Fang H; Qi SN; Wang H; Wang WH; Song YW; Lu J; Jin J; Wang SL; Liu YP; Lu N; Liu XF; Yu ZH
Clin Cancer Res; 2009 Apr; 15(8):2905-12. PubMed ID: 19318493
[TBL] [Abstract][Full Text] [Related]
32. Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer.
Wen S; He Y; Wang L; Zhang J; Quan C; Niu Y; Huang H
Oncogene; 2020 Oct; 39(42):6556-6571. PubMed ID: 32917955
[TBL] [Abstract][Full Text] [Related]
33. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma.
Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X
Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328
[TBL] [Abstract][Full Text] [Related]
34. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
[TBL] [Abstract][Full Text] [Related]
35. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.
Fang F; Lu J; Sang X; Tao YF; Wang JW; Zhang ZM; Zhang YP; Li XL; Xie Y; Wu SY; Chu XR; Li G; Wu D; Chen YL; Yu JJ; Jia SQ; Feng CX; Tian YY; Li ZH; Ling J; Hu SY; Pan J
J Exp Clin Cancer Res; 2022 Jul; 41(1):225. PubMed ID: 35842703
[TBL] [Abstract][Full Text] [Related]
36. Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous system.
Li X; Yu H; Fu X; Zhang L; Li X; Li L; Wang X; Sun Z; Zhang X; Li Z; Wu J; Chang Y; Yan J; Zhou Z; Nan F; Wu X; Tian L; Zhang M
Hematol Oncol; 2023 Apr; 41(2):267-274. PubMed ID: 34061378
[TBL] [Abstract][Full Text] [Related]
37. CircKIF4A Is a Prognostic Factor and Modulator of Natural Killer/T-Cell Lymphoma Progression.
He R; Wen W; Fu B; Zhu R; Chen G; Bai S; Cao X; Wang H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230873
[No Abstract] [Full Text] [Related]
38. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1.
Baytak E; Gong Q; Akman B; Yuan H; Chan WC; Küçük C
Tumour Biol; 2017 May; 39(5):1010428317701648. PubMed ID: 28468592
[TBL] [Abstract][Full Text] [Related]
39. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
Gen Y; Muramatsu T; Inoue J; Inazawa J
Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
[TBL] [Abstract][Full Text] [Related]
40. Novel targets for natural killer/T-cell lymphoma immunotherapy.
Kumai T; Kobayashi H; Harabuchi Y
Immunotherapy; 2016; 8(1):45-55. PubMed ID: 26642249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
